- Home
- JCSE vs EDSA Comparison
JCSE vs EDSA Comparison
Compare JCSE & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- EDSA
- Stock Information
- Founded
- JCSE 1999
- EDSA 2015
- Country
- JCSE Singapore
- EDSA Canada
- Employees
- JCSE N/A
- EDSA N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- JCSE Consumer Discretionary
- EDSA Health Care
- Exchange
- JCSE Nasdaq
- EDSA Nasdaq
- Market Cap
- JCSE 7.6M
- EDSA 6.2M
- IPO Year
- JCSE 2022
- EDSA N/A
- Fundamental
- Price
- JCSE $1.68
- EDSA $1.95
- Analyst Decision
- JCSE
- EDSA Strong Buy
- Analyst Count
- JCSE 0
- EDSA 1
- Target Price
- JCSE N/A
- EDSA $21.00
- AVG Volume (30 Days)
- JCSE 26.7K
- EDSA 28.9K
- Earning Date
- JCSE 10-30-2024
- EDSA 02-11-2025
- Dividend Yield
- JCSE 5.33%
- EDSA N/A
- EPS Growth
- JCSE N/A
- EDSA N/A
- EPS
- JCSE 0.12
- EDSA N/A
- Revenue
- JCSE $14,723,999.00
- EDSA N/A
- Revenue This Year
- JCSE N/A
- EDSA N/A
- Revenue Next Year
- JCSE N/A
- EDSA N/A
- P/E Ratio
- JCSE $13.69
- EDSA N/A
- Revenue Growth
- JCSE N/A
- EDSA N/A
- 52 Week Low
- JCSE $0.60
- EDSA $1.55
- 52 Week High
- JCSE $2.39
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- JCSE 67.11
- EDSA 52.19
- Support Level
- JCSE $1.43
- EDSA $1.83
- Resistance Level
- JCSE $1.58
- EDSA $2.06
- Average True Range (ATR)
- JCSE 0.08
- EDSA 0.20
- MACD
- JCSE 0.03
- EDSA 0.03
- Stochastic Oscillator
- JCSE 93.94
- EDSA 44.11
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.